Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Zimmermann

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Natural Products|January 31, 2014
Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorataElke H Heiss, Thi Van Anh Tran, Kristin Zimmermann, et al.
Scientific Reports|February 10, 2016
Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylationElke H Heiss, Rongxia Liu, Birgit Waltenberger, et al.
BMC Cancer|November 10, 2024
The impact of curative cancer treatment on sexual health - clinical results from the EORTC QLQ-SH22 validation studyAnne S Oberguggenberger, Veronika I Engele, Claudia Schmalz, et al.
World Journal of Urology|May 17, 2021
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomyPawel Rajwa, Victor M Schuettfort, Fahad Quhal, et al.
Clinical Genitourinary Cancer|November 12, 2021
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial CarcinomaKeiichiro Mori, Satoshi Katayama, Ekaterina Laukhtina, et al.
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
Minerva Urology and Nephrology|June 11, 2021
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, Kilian Gust, David D'Andrea, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
European Urology Focus|June 15, 2021
Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-AnalysisEkaterina Laukhtina, Pawel Rajwa, Keiichiro Mori, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Natural Products|January 31, 2014
Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorataElke H Heiss, Thi Van Anh Tran, Kristin Zimmermann, et al.
Scientific Reports|February 10, 2016
Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylationElke H Heiss, Rongxia Liu, Birgit Waltenberger, et al.
BMC Cancer|November 10, 2024
The impact of curative cancer treatment on sexual health - clinical results from the EORTC QLQ-SH22 validation studyAnne S Oberguggenberger, Veronika I Engele, Claudia Schmalz, et al.
World Journal of Urology|May 17, 2021
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomyPawel Rajwa, Victor M Schuettfort, Fahad Quhal, et al.
Clinical Genitourinary Cancer|November 12, 2021
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial CarcinomaKeiichiro Mori, Satoshi Katayama, Ekaterina Laukhtina, et al.
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
Minerva Urology and Nephrology|June 11, 2021
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, Kilian Gust, David D'Andrea, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
European Urology Focus|June 15, 2021
Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-AnalysisEkaterina Laukhtina, Pawel Rajwa, Keiichiro Mori, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Pageof 3